One-step size-controlled synthesis of functional graphene oxide/silver nanocomposites at room temperature

A stable aqueous suspension of functional graphene oxide/silver nanocomposite (FGO/Ag) was prepared in an alkaline medium by a simple room temperature stirring method. Functional graphene oxide (FGO) served as substrate, reducing agent and stabilizer for the silver nanoparticles (Ag-NPs). The pH of the solution played a prominent role in the formation of the Ag-NPs. The morphology of the nanoparticles (NPs) could be controlled by adjusting the pH between 9.51 and 12.62 by adding NaOH solution. The aqueous stability of the nanocomposites was greatly improved by the attached functional groups. UV-visible spectroscopy, transmission electron microscopy (TEM) and field emission scanning electron microscopy (FESEM) images suggested the formation of spherical, Ag-NPs with a narrow size distribution at pH 11.40. The nanocomposites showed high bactericidal activity against Escherichia coli bacteria and also enhancement in Raman intensity due to surface enhanced Raman scattering (SERS), which was found to be dependent on the size distribution of the Ag-NPs. This work provides a simple, scalable and environmentally friendly approach to the preparation of a FGO/Ag nanocomposite with promising antibacterial and SERS properties

Highly efficient preparation of ZnO nanorods decorated reduced graphene oxide nanocomposites

A one-step method for the synthesis of zinc oxide/reduced graphene oxide (ZnO/rGO) nanocomposites by a hydrothermal technique is reported. This simple method involves a hydrothermal treatment of a solution comprising graphene oxide (GO), Zn(CH3COO)2.2H2O, NaOH and NH3.H2O. The concentration of GO as a starting material plays an important role in the density distribution of ZnO nanorods on the rGO sheets and on the percentage of the formation of ZnO/rGO nanocomposites. The resulting rod-like ZnO nanoparticles formed on the rGO sheets, in high density, has a potential in the gas sensing application

Tailoring morphological characteristics of zinc oxide using a one-step hydrothermal method for photoelectrochemical water splitting application

In the present paper describe the zinc oxide (ZnO) with various morphologies have been synthesized using the one-step hydrothermal method, in which the growth of ZnO nanostructures are significantly tailored by adjusting the pH level between 9 and 12 using 0.1 M Sodium hydroxide (NaOH). Significant results reveal the morphological properties of ZnO nanostructures varied with different pH values with the formation of ZnO nanostructures have different morphological such as a baton, star, flower, and rod-like structures. The present results show the rod-like structure of ZnO nanostructures exhibits the highest photocurrent density of 746.61 μAcm−2 (at 1.23 V vs RHE) under simulated solar AM 1.5G illumination in Potassium hydroxide (KOH) medium, also the other morphologies. The dependent of the photoelectrochemical (PEC) water splitting properties on the different morphological of ZnO nanostructures are studied. Achieving the morphological evolution mechanism has become one of the method to obtain the production of the hydrogen growth regime used for solar energy conversion and their applied storage potentials. The application of the ZnO nanostructures for PEC water splitting was proposed with the adoption of screen-printed carbon electrodes (SPCEs). These are to quantify the best degree of the highest photocurrent density with one-step tailoring with an ideal modeling system to enhance PEC water splitting performances. Thus, the screen-printed carbon electrodes (SPEs) has been used as an alternative method for fabrication and photoelectrodes testings. © 2019 Hydrogen Energy Publications LL

Effects of Cobalt Loading, Particle Size, and Calcination Condition on Co/CNT Catalyst Performance in Fischer–Tropsch Reactions

The strong electrostatic adsorption (SEA) method was applied to the synthesis of a cobalt (Co) catalyst on a multi-walled carbon nanotube (CNT) support. In order to uptake more of the cobalt cluster with higher dispersion, the CNT was functionalized via acid and thermal treatment. The Co/CNT catalyst samples were characterized by a range of methods including the Brunauer–Emmet–Teller (BET) surface area analyzer, transmission electron microscopy (TEM), X-ray powder diffraction (XRD) analysis, atomic absorption spectroscopy (AAS), and H2-temperature programmed reduction (H2-TPR) analysis. The data from the TEM images revealed that the catalyst was highly dispersed over the external and internal walls of the CNT and that it demonstrated a narrow particle size of 6–8 nm. In addition, the data from the H2-TPR studies showed a lower reduction temperature (420 °C) for the pre-treated catalyst samples. Furthermore, a Fischer–Tropsch synthesis (FTS) reaction was chosen to evaluate the Co/CNT catalyst performance by using a fixed-bed microreactor at different parameters. Finally finding the optimum value of the cobalt loading percentage, particle size, and calcination conditions of Co/CNT catalyst resulted in a CO conversion and C5+ selectivity of 58.7% and 83.2%, respectively

Effect of Cobalt Catalyst Confinement in Carbon Nanotubes Support on Fischer-Tropsch Synthesis Performance

Pre-treating the multi-walled carbon nanotubes (CNTs) support by refluxing in 35 vol% nitric acid followed by heating at the temperature of 600 to 900 °C resulted in the formation of defects on the CNTs. Increasing the temperature of the pre-treatment of the CNTs from 600 °C to 900 °C, enhanced the fraction of cobalt-oxide nanoparticles encapsulated in the channels of CNTs from 31% to 70%. The performance of Co/CNTs in Fischer-Tropsch synthesis (FTS) was evaluated in a fixed-bed micro-reactor at a temperature of 240 °C and a pressure of 2.0 MPa. The highest CO conversion obtained over Co/CNTs.A.900 was 59% and it dropped by ~3% after 130 h of time-on-stream. However, maximum CO conversion using Co/CNTs.A.600 catalysts was 28% and it decreased rapidly by about 54% after 130 h of time-on-stream. These findings show that the combined acid and thermal pre-treatment of CNTs support at 900 °C has improved the stability and activity of the Co/CNTs catalyst in FTS

Effect of Manganese on Co–Mn/CNT Bimetallic Catalyst Performance in Fischer–Tropsch Reaction

Cobalt (Co) catalyst is supported by carbon nanotubes (CNT) using a strong electrostatic adsorption (SEA) method. To promote activity and selectivity as well as find the optimum loading percentage and its effect on catalyst performance, manganese (Mn) has been added to the Co/CNT catalyst. Samples were characterized by a scanning electron microscope (SEM-EDX), transmission electron microscope (TEM), hydrogen temperature programmed reduction (H2-TPR), Zeta potential, Brunauer-Emmett-Teller (BET) analysis, X-ray diffraction (XRD), and X-ray spectroscopy (XPS). TEM images illustrated an intake of metal particles which were highly dispersed, having a narrow particle size distribution of 6-8 nm to the external and internal CNT support. H2-TPR showed a lower temperature reduction with Mn at 420 °C for Fischer-Tropsch synthesis (FTS) reaction. The Co-Mn/CNT catalyst performance test for FTS was performed at a temperature of 240 °C in a fixed-bed micro-reactor at a pressure of 2.0 MPa. The addition of manganese resulted in a lower methane selectivity and a higher C5+ product with an optimum percentage of 5% of manganese. CO conversion was 86.6% and had a C5+ selectivity of 81.5%, which was higher than the catalysts obtained using only Co on pretreated CNT. © 2019 by the authors

Effect of Pressure, H2/CO Ratio and Reduction Conditions on Co–Mn/CNT Bimetallic Catalyst Performance in Fischer–Tropsch Reaction

The effects of process conditions on Fischer–Tropsch Synthesis (FTS) product distributions were studied using a fixed-bed microreactor and a Co–Mn/CNT catalyst. Cobalt and Manganese, supported on Carbon Nanotubes (CNT) catalyst were prepared by a Strong Electrostatic Adsorption (SEA) method. CNT supports were initially acid and thermally treated in order to functionalize support to uptake more Co clusters. Catalyst samples were characterized by Transmitted Electron Microscope (TEM), particle size analyzer, and Thermal Gravimetric Analysis (TGA). TEM images showed catalyst metal particle intake on CNT support with different Co and Mn loading percentage. Performance test of Co–Mn/CNT in Fischer–Tropsch synthesis (FTS) was carried out in a fixed-bed micro-reactor at different pressures (from 1 atm to 25 atm), H2/CO ratio (0.5–2.5), and reduction temperature and duration. The reactor was connected to the online Gas Chromatograph (GC) for product analysis. It was found that the reaction conditions have the dominant effect on product selectivity. Cobalt catalyst supported on acid and thermal pre-treated CNT at optimum reaction condition resulted in CO conversion of 58.7% and C5+ selectivity of 59.1%

Proceedings Of The 7Th Biannual International Symposium On Nasopharyngeal Carcinoma 2015

A1 Hope and despair in the current treatment of nasopharyngeal cancer, IB Tan, I1 NPC international incidence and risk factors, Ellen T Chang, I2 Familial nasopharyngeal carcinoma and the use of biomarkers, Chien-Jen Chen, Wan-Lun Hsu, Yin-Chu Chien, I3 Genetic susceptibility risk factors for sporadic and familial NPC: recent findings, Allan Hildesheim, I5 Genetic and environmental risk factors for nasopharyngeal cancer in Southeast Asia, James D McKay, Valerie Gaborieau, Mohamed Arifin Bin Kaderi, Dewajani Purnomosari, Catherine Voegele, Florence LeCalvez-Kelm, Graham Byrnes, Paul Brennan, Beena Devi, I6 Characterization of the NPC methylome identifies aberrant epigenetic disruption of key signaling pathways and EBV-induced gene methylation, Li L, Zhang Y, Fan Y, Sun K, Du Z, Sun H, Chan AT, Tsao SW, Zeng YX, Tao Q, I7 Tumor exosomes and translational research in NPC, Pierre Busson, Claire Lhuillier, Olivier Morales, Dhafer Mrizak, Aurore Gelin, Nikiforos Kapetanakis, Nadira Delhem, I8 Host manipulations of the Epstein-Barr virus EBNA1 protein, Sheila Mansouri, Jennifer Cao, Anup Vaidya, and Lori Frappier, I9 Somatic genetic changes in EBV-associated nasopharyngeal carcinoma, Lo Kwok Wai, I10 Preliminary screening results for nasopharyngeal carcinoma with ELISA-based EBV antibodies in Southern China, Sui-Hong Chen, Jin-lin Du, Ming-Fang Ji, Qi-Hong Huang, Qing Liu, Su-Mei Cao, I11 EBV array platform to screen for EBV antibodies associated with NPC and other EBV-associated disorders, Denise L. Doolan, Anna Coghill, Jason Mulvenna, Carla Proietti, Lea Lekieffre, Jeffrey Bethony, and Allan Hildesheim, I12 The nasopharyngeal carcinoma awareness program in Indonesia, Renske Fles, Sagung Rai Indrasari, Camelia Herdini, Santi Martini, Atoillah Isfandiari, Achmad Rhomdoni, Marlinda Adham, Ika Mayangsari, Erik van Werkhoven, Maarten Wildeman, Bambang Hariwiyanto, Bambang Hermani, Widodo Ario Kentjono, Sofia Mubarika Haryana, Marjanka Schmidt, IB Tan, I13 Current advances and future direction in nasopharyngeal cancer management, Brian O’Sullivan, I14 Management of juvenile nasopharyngeal cancer, Enis Ozyar, I15 Global pattern of nasopharyngeal cancer: correlation of outcome with access to radiotherapy, Anne WM Lee, I16 The predictive/prognostic biomarker for nasopharyngeal carcinoma, Mu-Sheng Zeng, I17 Effect of HLA and KIR polymorphism on NPC risk, Xiaojiang Gao, Minzhong Tang, Pat Martin, Yi Zeng, Mary Carrington, I18 Exploring the Association between Potentially Neutralizing Antibodies against EBV Infection and Nasopharyngeal Carcinoma, Anna E Coghill, Wei Bu, Hanh Nguyen, Wan-Lun Hsu, Kelly J Yu, Pei-Jen Lou, Cheng-Ping Wang, Chien-Jen Chen, Allan Hildesheim, Jeffrey I Cohen, I19 Advances in MR imaging in NPC, Ann D King, O1 Epstein-Barr virus seromarkers and risk of nasopharyngeal carcinoma: the gene-environment interaction study on nasopharyngeal carcinoma in Taiwan, Yin-Chu Chien, Wan-Lun Hsu, Kelly J Yu, Tseng-Cheng Chen, Ching-Yuan Lin, Yung-An Tsou, Yi-Shing Leu, Li-Jen Laio, Yen-Liang Chang, Cheng-Ping Wang, Chun-Hun Hua, Ming-Shiang Wu, Chu-Hsing Kate Hsiao, Jehn-Chuan Lee, Ming-Hsui Tsai, Skye Hung-Chun Cheng, Pei-Jen Lou, Allan Hildesheim, Chien-Jen Chen, O2 Familial tendency and environmental co-factors of nasopharyngeal carcinoma: the gene-environment interaction study on nasopharyngeal carcinoma in Taiwan, Wan-Lun Hsu, Kelly J Yu, Yin-Chu Chien, Tseng-Cheng Chen, Ching-Yuan Lin, Yung-An Tsou, Yi-Shing Leu, Li-Jen Liao, Yen-Liang Chang, Tsung-Lin Yang, Chun-Hun Hua, Ming-ShiangWu, Chu-Hsing Kate Hsiao, Jehn-ChuanLee, Ming-Hsui Tsai, Skye Hung-Chun Cheng, Jenq-Yuh Ko, Allan Hildesheim, Chien-Jen Chen, O3 The genetic susceptibility and prognostic role of TERT-CLPTM1L and genes in DNA damage pathways in NPC, Josephine Mun Yee Ko, Wei Dai, Dora Kwong, Wai Tong Ng, Anne Lee, Roger Kai Cheong Ngan, Chun Chung Yau, Stewart Tung, Maria Li Lung, O4 Long term effects of NPC screening, Mingfang Ji, Wei Sheng, Mun Hon Ng, Weimin Cheng, Xia Yu, Biaohua Wu, Kuangrong Wei, Jun Zhan, Yi Xin Zeng, Su Mei Cao, Ningshao Xia, Yong Yuan, O5 Risk prediction of nasopharyngeal carcinoma by detecting host genetic and Epstein-Barr virus variation in saliva, Qian Cui, Miao Xu, Jin-Xin Bei, Yi-Xin Zeng, O6 Patterns of care study in Turkish nasopharyngeal cancer patients (NAZOTURK): A Turkish Radiation Oncology Association Head and Neck Cancer Working Group Study, B Şahin, A Dizman, M Esassolak, A Saran İkizler, HC Yıldırım, M Çaloğlu, B Atalar, F Akman, C Demiroz, BM Atasoy, E Canyilmaz, S Igdem, G Ugurluer, T Kütük, M Akmansoy, E Ozyar, O7 Long term outcome of intensity modulated radiotherapy in nasopharyngeal carcinoma in National Cancer Centre Singapore, Kiattisa Sommat, Fu Qiang Wang, Li-Lian Kwok, Terence Tan, Kam Weng Fong, Yoke Lim Soong, Shie Lee Cheah, Joseph Wee, O8 International phase II randomized study on the addition of docetaxel to the combination of cisplatin and 5-fluorouracil in the induction treatment for nasopharyngeal carcinoma in children and adolescents, M Casanova, E Özyar, C Patte, D Orbach, A Ferrari, VF Cristine, H Errihani, J Pan, L Zhang, S Liji, K Grzegorzewski, L Gore, A Varan, O9 Prognostic impact of metastatic status in patients with nasopharyngeal carcinoma, Susanna Hilda Hutajulu, Guntara Khuzairi, Camelia Herdini, Henry Kusumo, Mardiah Suci Hardianti, Kartika Widayati Taroeno-Hariadi, Ibnu Purwanto, Johan Kurnianda, O10 Development of small molecule inhibitors of latent Epstein-Barr virus infection for the treatment of nasopharyngeal carcinoma, Troy E. Messick, Kimberly Malecka, Lois Tolvinski, Samantha Soldan, Julianna Deakyne, Hui Song, Antonio van den Heuvel, Baiwei Gu, Joel Cassel, Mark McDonnell, Garry R Smith, Venkata Velvadapu, Haiyan Bian, Yan Zhang, Marianne Carlsen, Shuai Chen, Alastair Donald, Christian Lemmen, Allen B Reitz, Paul M Lieberman, O11 Therapeutic targeting of cancer stem-like cells using a Wnt modulator, ICG-001, enhances the treatment outcome of EBV-positive nasopharyngeal carcinoma, King Chi Chan, Lai Sheung Chan, Kwok Wai Lo, Timothy Tak Chun Yip, Roger Kai Cheong Ngan, Michael Kahn, Maria Li Lung, Nai Ki Mak, O12 Role of micro-RNA in NPC biology, Fei-Fei Liu, O13 Expansion of EBNA1- and LMP2-specific effector T lymphocytes from patients with nasopharyngeal carcinoma without enhancement of regulatory T cells, Wafa Khaali; Juliette Thariat; Laurence Fantin; Flavia Spirito; Meriem Khyatti; El Khalil Ben Driss; Sylvain Olivero; Janet Maryanski; Alain Doglio, O14 The experience of patients’ life after amifostine radiotherapy treatment (ART) for nasopharyngeal carcinoma (NPC), Mengxue Xia, Yunfei Xia, Hui Chang, Rachel Shaw, O15 Analysis of mitochondrial DNA mutation in latent membrane protein-1 positive nasopharyngeal carcinoma, Pudji Rahaju, O16 Factors influencing treatment adherence of nasopharyngeal cancer and the clinical outcomes: a hospital-based study, Mardiah Suci Hardianti, Sindhu Wisesa, Kartika Widayati Taroeno-Harijadi, Ibnu Purwanto, Bambang Hariwiyanto, Wigati Dhamiyati, Johan Kurnianda, O17 Chromosomal breaks mediated by bile acid-induced apoptosis in nasopharyngeal epithelial cells: in relation to matrix association region/scaffold attachment region, Sang-Nee Tan, Sai-Peng Sim, O18 Expression of p53 (wild type) on nasopharyngeal carcinoma stem cell that resistant to radiotherapy, Muhtarum Yusuf, Ahmad C Romdhoni, Widodo Ario K, Fedik Abdul Rantam, O19 Mathematical model of nasopharyngeal carcinoma in cellular level, Sugiyanto, Lina Aryati, Fajar Adi-Kusumo, Mardiah Suci Hardianti, O20 Differential expression of microRNA-21 on nasopharyngeal carcinoma plasma patient, SY Bintoro, R Oktriani, C. Herawati, A Surono, Sofia M. Haryana, O21 Therapeutic targeting of an oncogenic fibroblast growth factor-FGF19, which promotes proliferation and induces EMT of carcinoma cells through activating ERK and AKT signaling, L. Zhong, L. Li, B. B. Ma, A. T. Chan, Q. Tao, O22 Resist nasopharyngeal carcinoma (NPC): next generation T cells for the adoptive immunotherapy of NPC, M. Kalra, M. Ngo, S. Perna, A. Leen, N. Lapteva, C. M. Rooney, S. Gottschalk, O23 The correlation of heat shock protein 70 expressions and staging of nasopharyngeal carcinoma, Elida Mustikaningtyas, Sri Herawati, Achmad C Romdhoni, O24 Epstein-Barr virus serological profiles of nasopharyngeal carcinoma - A tribute to Werner Henle, Mingfang Ji, YaruiXu, Weimin Cheng, ShengxiangGe, Fugui Li, M. H. Ng, O25 Targeting the apoptosis pathway using combination TLR3 agonist with anti-survivin molecule (YM-155) in nasopharyngeal carcinoma, Louise SY Tan, Benjamin Wong, CM Lim, O26 The resistance mechanism of nasopharyngeal cancer stem cells to cisplatin through expression of CD44, Hsp70, p53 (wild type), Oct-4, and ß-catenin encoded-genes, Achmad C Romdhoni, Fedik A. Rantam, Widodo Ario Kentjono, P1 Prevalence of nasopharyngeal carcinoma patients at Departement of Otorhinolaringology-Head and Neck Surgery, Dr. Hasan Sadikin general hospital, Bandung, Indonesia in 2010-2014, Deasy Z Madani, Nur Akbar, Agung Dinasti Permana, P2 Case report on pediatric nasopharyngeal carcinoma at Dr. Sardjito Hospital, Yogyakarta, Camelia Herdini, Sagung Rai Indrasari, Jajah Fachiroh, Dwi Hartati, T. Baning Rahayudjati, P3 Report on loco regionally advanced nasopharyngeal cancer patients treated with induction chemotherapy followed by concurrent chemo-radiation therapy, Iswandi Darwis, Susanna Hilda Hutajulu, Bambang Hariwiyanto, Wigati Dhamiyati, Ibnu Purwanto, Kartika Widayati Taroeno-Hariadi, Johan Kurnianda, P4 Sex and age differences in the survival of patients with nasopharyngeal carcinoma, Sindhu Wisesa, Mardiah Suci Hardianti, Susanna Hilda Hutajulu, Kartika Widayati Taroeno-Harijadi, Ibnu Purwanto, Camelia Herdini, Wigati Dhamiyati, Johan Kurnianda, P5 Impact of delayed diagnosis and delayed therapy in the treatment outcome of patients with nasopharyngeal carcinoma, Khoirul Anwar, Susanna Hilda Hutajulu, Sagung Rai Indrasari, Sri Retna Dwidanarti, Ibnu Purwanto, Kartika Widayati Taroeno-Hariadi, Johan Kurnianda, P6 Anaysis of pretreatment anemia in nasopharyngeal cancer patients undergoing neoadjuvant therapy, Dominicus Wendhy Pramana, Susanna Hilda Hutajulu, Bambang Hariwiyanto, Wigati Dhamiyati, Ibnu Purwanto, Kartika Widayati Taroeno-Hariadi, Johan Kurnianda, P7 Results of treatment with neoadjuvant cisplatin-5FU in locally advanced nasopharyngeal carcinoma: a local experience, Diah Ari Safitri, Susanna Hilda Hutajulu, Camelia Herdini, Sri Retna Dwi Danarti, Ibnu Purwanto, Kartika Widayati Taroeno-Hariadi, Johan Kurnianda, P8 Geriatrics with nasopharyngeal cancer, Suryo A Taroeno, Sindhu Wisesa, Kartika Widayati Taroeno-Hariadi, Ibnu Purwanto, Bambang Hariwiyanto, Wigati Dhamiyati, Johan Kurnianda, P9 Correlation of lymphocyte to monocyte and neutrophil to lymphocyte ratio to the response of cisplatin chemoradiotheraphy in locally advance nasopharyngeal carcinoma, I. Wijaya, A. Oehadian, D. Prasetya, P10 Prediction of nasopharyngeal carcinoma risk by Epstein-Barr virus seromarkers and environmental co-factors: the gene-environment interaction study on nasopharyngeal carcinoma in Taiwan, Wan-Lun Hsu, Yin-Chu Chien, Kelly J Yu, Cheng-Ping Wang, Ching-Yuan Lin, Yung-An Tsou, Yi-Shing Leu, Li-Jen Liao, Yen-Liang Chang191,192, Jenq-Yuh Ko, Chun-Hun Hua, Ming-Shiang Wu, Chu-Hsing Kate Hsiao, Jehn-Chuan Lee, Ming-Hsui Tsai, Skye Hung-Chun Cheng, Pei-Jen Lou, Allan Hildesheim, Chien-Jen Chen, P11 Non-viral risk factors for nasopharyngeal carcinoma in West Sumatra, Indonesia, Sukri Rahman, Bestari J. Budiman, Novialdi, Rahmadona, Dewi Yuri Lestari, P12 New prototype Vidas EBV IgA quick: performance on Chinese and Moroccan populations, C. Yin, A. Foussadier, E. Blein, C. Chen, N. Bournet Ammour, M. Khiatti, S. Cao, P13 The expression of EBV-LMP1 and VEGF as predictors and plasma EBV-DNA levels as early marker of distant metastasis after therapy in nasopharyngeal cancer, Dewi Syafriyetti Soeis Marzaini, P14 Characteristics and factors influencing subjects refusal for blood samples retrieval: lesson from NPC case control study in Yogyakarta – Indonesia, Dwi Hartati, Baning Rahayujati, Camelia Herdini, Jajah Fachiroh, P15 Expression of microRNA BART-7-3p and mRNA PTEN on blood plasma of patients with nasopharyngeal carcinoma, L. Gunawan, S. Mubarika Haryana, A. Surono, C. Herawati, P16 IgA response to native early antigen (IgA-EAext) of Epstein-Barr virus (EBV) in healthy population and nasopharyngeal carcinoma (NPC) patients: the potential for diagnosis and screening tools, Michael Hartono, Jajah Fachiroh, Umi Intansari, Dewi Kartikawati Paramita, P17 IgA responses against Epstein-Barr Virus Early Antigen (EBV-EA) peptides as potential candidates of nasopharyngeal carcinoma detection marker, Akmal Akbar, Jajah Fachiroh, Dewi Kartikawati Paramita, P18 Association between smoking habit and IgA-EBV titer among healthy individuals in Yogyakarta, Indonesia, Benny Hermawan, T Baning Rahayudjati, Dewi K Paramita, Jajah Fachiroh, P19 Epstein-Barr virus IgA titer comparison of healthy non-family individuals and healthy first degree family of NPV patients, Gabriella Argy, Jajah Fachiroh, Dewi Kartikawati Paramita, Susanna Hilda Hutajulu, P20 Identification of EBV Early Antigen (EA) derived peptides for NPC diagnosis, Theodora Caroline Sihotang, Jajah Fachiroh, Umi Intansari, Dewi Kartikawati Paramita, P21 Host-pathogen study: relative expression of mRNA BRLF1 Epstein-Barr virus as a potential biomarker for tumor progressivity and polymorphisms of TCRBC and TCRGC2 host genes related to genetic susceptibility on nasopharyngeal carcinoma, Daniel Joko Wahyono, Purnomo Soeharso, Dwi Anita Suryandari, Lisnawati, Zanil Musa, Bambang Hermani, P22 In vitro efficacy of silvestrol and episilvestrol, isolated from Borneo, on nasopharyngeal carcinoma, a major cancer in Borneo, Maelinda Daker, Yeo Jiun Tzen, Norhasimah Bakar, Asma’ Saiyidatina Aishah Abdul Rahman, Munirah Ahmad, Yeo Tiong Chia, Alan Khoo Soo Beng, P23 The expression of mir-141 in patients with nasopharyngeal cancer, Widyandani Sasikirana, Tirta Wardana, Muhammad Radifar, Cita Herawati, Agus Surono, Sofia Mubarika HaryanaPubMe